CCM
UTHR icon

Coldstream Capital Management’s United Therapeutics UTHR Stock Holding History

Coldstream Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Sell
2,255
-40
-2% -$22.5K 0.02% 427
2026
Q1 		$1.36M Sell
2,295
-58
-2% -$28.9K 0.02% 396
2025
Q4 		$1.15M Buy
2,353
+68
+3% +$31.7K 0.01% 410
2025
Q3 		$958K Buy
2,285
+140
+7% +$47.1K 0.01% 473
2025
Q2 		$616K Buy
2,145
+43
+2% +$12.9K 0.01% 572
2025
Q1 		$648K Sell
2,102
-77
-4% -$26.4K 0.01% 500
2024
Q4 		$769K Buy
2,179
+13
+0.6% +$4.78K 0.02% 438
2024
Q3 		$779K Buy
2,166
+79
+4% +$26.7K 0.02% 453
2024
Q2 		$665K Buy
2,087
+81
+4% +$21.4K 0.02% 444
2024
Q1 		$461K Sell
2,006
-39
-2% -$8.8K 0.01% 586
2023
Q4 		$450K Sell
2,045
-82
-4% -$18.9K 0.01% 552
2023
Q3 		$480K Buy
2,127
+33
+2% +$7.6K 0.02% 442
2023
Q2 		$462K Buy
2,094
+86
+4% +$19K 0.01% 475
2023
Q1 		$450K Sell
2,008
-15
-0.7% -$3.7K 0.02% 472
2022
Q4 		$563K Buy
+2,023
New +$511K 0.02% 398
2022
Q2 		$468K Buy
1,989
+215
+12% +$43.7K 0.02% 413
2022
Q1 		$318K Sell
1,774
-49
-3% -$9.34K 0.01% 548
2021
Q4 		$394K Buy
+1,823
New +$358K 0.01% 510

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Coldstream Capital Management's UTHR Position: Q2 2026 in Review

Coldstream Capital Management reduced its United Therapeutics (UTHR) stake by 1.7% in Q2 2026, selling an estimated $22.5K and leaving 2,255 shares worth $1.22M. The position accounts for 0.02% of the portfolio, ranked #427.

Coldstream Capital Management first reported a position in UTHR in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.36M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Coldstream Capital Management held 2,255 shares of United Therapeutics worth $1.22M as of Q2 2026.
  • Coldstream Capital Management sold 40 United Therapeutics shares in Q2 2026, an estimated $22.5K.
  • United Therapeutics made up 0.02% of Coldstream Capital Management's portfolio in Q2 2026, its #427 holding.
  • Coldstream Capital Management first reported a position in United Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Coldstream Capital Management's United Therapeutics position peaked at $1.36M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.